Canada markets closed

Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
1.7500+0.0400 (+2.34%)
At close: 04:00PM EST
1.7750 +0.02 (+1.43%)
After hours: 06:45PM EST
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-3,529,041
-1,830,047
-126,609
-119,327
Depreciation & amortization
36,605
29,076
13,864
10,755
Stock based compensation
3,413,728
1,606,020
476
771
Change in working capital
-110,600
-61,537
-26,515
10,577
Accounts receivable
-64,903
-114,094
-14,228
-1,843
Inventory
-2,386
-626
-2,736
0
Accounts Payable
4,417
-2,247
7,019
664
Other working capital
-344,778
-310,339
-193,651
-66,882
Other non-cash items
-26,524
-20,947
-1,061
-1,642
Net cash provided by operating activites
-313,038
-253,818
-135,830
-44,663
Cash flows from investing activities
Investments in property, plant and equipment
-31,740
-56,521
-57,821
-22,219
Acquisitions, net
-47,036
-12,040
0
0
Purchases of investments
-13,691
-5,000
0
-50,133
Other investing activites
-439
304
-9,300
-2,250
Net cash used for investing activites
-92,906
-73,257
-67,121
-74,602
Cash flows from financing activities
Debt repayment
-1,441
-1,123
-748
-828
Common stock repurchased
0
-24,998
0
-408
Other financing activites
-12,444
1,560,099
-
-
Net cash used privided by (used for) financing activities
-13,639
1,534,145
90,318
410,385
Net change in cash
-419,785
1,207,051
-112,633
291,120
Cash at beginning of period
1,765,295
385,877
498,510
207,390
Cash at end of period
1,345,712
1,592,928
385,877
498,510
Free Cash Flow
Operating Cash Flow
-313,038
-253,818
-135,830
-44,663
Capital Expenditure
-31,740
-56,521
-57,821
-22,219
Free Cash Flow
-344,778
-310,339
-193,651
-66,882